Key facts
- This page summarizes Paul Peloso's Form 4 filing for ACELYRIN, Inc. (SLRN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 06 Oct 2023, 17:55.
Paul Peloso - 04 Oct 2023 Form 4 Insider Report for ACELYRIN, Inc. (SLRN)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- SLRN
- Reported as of
- 04 Oct 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Oct 2023, 17:55:04 UTC
- Prior SEC filing
- 18 Aug 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mina Kim, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Paul Peloso filed Form 4 for ACELYRIN, Inc. (SLRN) on 06 Oct 2023.
Change
- Previous filing in this sequence was filed on 18 Aug 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SLRN
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +39,133
- Change %
- Price
- $0.000000
- Shares after
- 39,133
- Date
- 04 Oct 2023
- Ownership
- See footnote
- Footnotes
- F1, F2
SLRN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 121,511
- Date
- 04 Oct 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, from Woodland Hills Partner LLC (the "LLC") to the Reporting Person, a limited partner of the LLC, without additional consideration. This distribution arises from the purchase of preferred stock by the Reporting Person as a limited partner in the LLC on the same pricing terms as the other participating investors in each round of financing.
Footnote F2
Shares held directly by The Peloso Riley Family Trust, 2006, for which the Reporting Person serves as co-trustee.